• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖相关性肾小球病:从发病机制到治疗靶点

Obesity-Related Glomerulopathy: From Mechanism to Therapeutic Target.

作者信息

Wei Lifang, Li Ye, Yu Yue, Xu Minmin, Chen Huilan, Li Lijie, Peng Ting, Zhao Kang, Zhuang Yongze

机构信息

Department of Nephrology, The Third People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, People's Republic of China.

The Third People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, People's Republic of China.

出版信息

Diabetes Metab Syndr Obes. 2021 Oct 28;14:4371-4380. doi: 10.2147/DMSO.S334199. eCollection 2021.

DOI:10.2147/DMSO.S334199
PMID:34737593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8560069/
Abstract

Obesity-related glomerulopathy (ORG) is a secondary glomerular disease caused by obesity, with clinical manifestations such as proteinuria and glomerulomegaly. Currently, the high incidence of obesity brings a change in the spectrum of kidney diseases across the globe, including China. ORG has become another important secondary nephropathy leading to end-stage renal disease (ESRD), and its incidence has increased significantly. This trend is bound to bring about a serious socioeconomic burden. Therefore, it is urgent to study its pathogenesis and intervention measures. Currently, the occurrence and development mechanisms in ORG are complicated by many factors, which are still unclear. In the past 20 years, with the continuous intensive research on mechanisms such as hypoxia in the metabolic process, immune inflammation, and pyroptosis, there have been new advances in the mechanism of ORG, especially the important role of inflammation in podocyte injury and its impact on the progress of ORG. Here, we briefly review the possible pathogenic role of the inflammasome in the podocyte damage in ORG and summarize the possible therapeutical strategies targeting inflammasome.

摘要

肥胖相关性肾小球病(ORG)是一种由肥胖引起的继发性肾小球疾病,临床表现为蛋白尿和肾小球肿大。目前,肥胖的高发病率导致全球包括中国在内的肾脏疾病谱发生变化。ORG已成为导致终末期肾病(ESRD)的另一种重要的继发性肾病,其发病率显著增加。这种趋势必然会带来严重的社会经济负担。因此,迫切需要研究其发病机制和干预措施。目前,ORG的发生和发展机制受多种因素影响,仍不明确。在过去20年里,随着对代谢过程中的缺氧、免疫炎症和细胞焦亡等机制的深入研究,ORG的机制有了新进展,尤其是炎症在足细胞损伤中的重要作用及其对ORG进展的影响。在此,我们简要综述炎性小体在ORG足细胞损伤中可能的致病作用,并总结针对炎性小体的可能治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/8560069/dfaa8e3718b4/DMSO-14-4371-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/8560069/dfaa8e3718b4/DMSO-14-4371-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b33/8560069/dfaa8e3718b4/DMSO-14-4371-g0001.jpg

相似文献

1
Obesity-Related Glomerulopathy: From Mechanism to Therapeutic Target.肥胖相关性肾小球病:从发病机制到治疗靶点
Diabetes Metab Syndr Obes. 2021 Oct 28;14:4371-4380. doi: 10.2147/DMSO.S334199. eCollection 2021.
2
Coptidis Rhizoma inhibits NLRP3 inflammasome activation and alleviates renal damage in early obesity-related glomerulopathy.黄连抑制 NLRP3 炎性小体激活并减轻肥胖相关性肾小球病早期的肾脏损伤。
Phytomedicine. 2018 Oct 1;49:52-65. doi: 10.1016/j.phymed.2018.05.019. Epub 2018 Jun 7.
3
Purinergic 2X7 Receptor is Involved in the Podocyte Damage of Obesity-Related Glomerulopathy via Activating Nucleotide-Binding and Oligomerization Domain-Like Receptor Protein 3 Inflammasome.嘌呤能 2X7 受体通过激活核苷酸结合寡聚化结构域样受体蛋白 3 炎症小体参与肥胖相关性肾小球病的足细胞损伤。
Chin Med J (Engl). 2018 Nov 20;131(22):2713-2725. doi: 10.4103/0366-6999.245270.
4
CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy.CD36 介导的脂质积累和 NLRP3 炎性小体的激活导致肥胖相关性肾小球病中的足细胞损伤。
Mediators Inflamm. 2019 Apr 11;2019:3172647. doi: 10.1155/2019/3172647. eCollection 2019.
5
Regulation of NLRP3 Inflammasome Activation and Inflammatory Exosome Release in Podocytes by Acid Sphingomyelinase During Obesity.肥胖时酸性鞘磷脂酶调节足细胞 NLRP3 炎性小体激活和炎症外泌体释放。
Inflammation. 2023 Oct;46(5):2037-2054. doi: 10.1007/s10753-023-01861-y. Epub 2023 Jul 21.
6
Targeting Renal Proximal Tubule Cells in Obesity-Related Glomerulopathy.靶向肥胖相关性肾小球病中的肾近端小管细胞
Pharmaceuticals (Basel). 2023 Sep 5;16(9):1256. doi: 10.3390/ph16091256.
7
Wen-Shen-Jian-Pi-Hua-Tan decoction protects against early obesity-related glomerulopathy by improving renal bile acid composition and suppressing lipogenesis, inflammation, and fibrosis.稳肾健脾化痰汤通过改善肾脏胆汁酸组成、抑制脂生成、炎症和纤维化来预防早期肥胖相关性肾小球病。
Phytomedicine. 2023 Jul 25;116:154861. doi: 10.1016/j.phymed.2023.154861. Epub 2023 May 4.
8
Podocyte lesions in patients with obesity-related glomerulopathy.肥胖相关性肾小球病患者的足细胞病变
Am J Kidney Dis. 2006 Nov;48(5):772-9. doi: 10.1053/j.ajkd.2006.07.025.
9
Obesity-related glomerulopathy: an emerging epidemic.肥胖相关肾小球病:一种新出现的流行病。
Kidney Int. 2001 Apr;59(4):1498-509. doi: 10.1046/j.1523-1755.2001.0590041498.x.
10
Adiponectin protects obesity-related glomerulopathy by inhibiting ROS/NF-κB/NLRP3 inflammation pathway.脂联素通过抑制 ROS/NF-κB/NLRP3 炎症途径保护肥胖相关性肾小球病。
BMC Nephrol. 2021 Jun 10;22(1):218. doi: 10.1186/s12882-021-02391-1.

引用本文的文献

1
Semaglutide and adenosine alleviate obesity-induced kidney injury, with observed modulation of the Txnip/NLRP3 pathway.司美格鲁肽和腺苷可减轻肥胖诱导的肾损伤,并观察到对Txnip/NLRP3通路的调节作用。
Diabetol Metab Syndr. 2025 May 24;17(1):164. doi: 10.1186/s13098-025-01736-2.
2
Obesity-Related Chronic Kidney Disease: From Diagnosis to Treatment.肥胖相关慢性肾脏病:从诊断到治疗
Diagnostics (Basel). 2025 Jan 14;15(2):169. doi: 10.3390/diagnostics15020169.
3
Definition and diagnostic criteria of clinical obesity.临床肥胖的定义和诊断标准。

本文引用的文献

1
Obesity in Patients with Type 1 Diabetes: Links, Risks and Management Challenges.1型糖尿病患者的肥胖:关联、风险及管理挑战
Diabetes Metab Syndr Obes. 2021 Jun 21;14:2807-2827. doi: 10.2147/DMSO.S223618. eCollection 2021.
2
Emodin Attenuated the Kidney Damage of High-Fat-Diet Mice via the Upregulation of Glucagon-Like Peptide-1 Receptor.大黄素通过上调胰高血糖素样肽-1 受体减轻高脂饮食诱导的小鼠肾损伤。
Biomed Res Int. 2021 May 31;2021:6662704. doi: 10.1155/2021/6662704. eCollection 2021.
3
Adiponectin protects obesity-related glomerulopathy by inhibiting ROS/NF-κB/NLRP3 inflammation pathway.
Lancet Diabetes Endocrinol. 2025 Mar;13(3):221-262. doi: 10.1016/S2213-8587(24)00316-4. Epub 2025 Jan 14.
4
Significantly higher rates of KIDINS220 polymorphisms in patients with obesity and end-stage renal disease.肥胖和终末期肾病患者中KIDINS220基因多态性的发生率显著更高。
Obes Pillars. 2024 Dec 5;13:100155. doi: 10.1016/j.obpill.2024.100155. eCollection 2025 Mar.
5
Nutritional assessment and medical dietary therapy for management of obesity in patients with non-dialysis chronic kidney disease: a practical guide for endocrinologist, nutritionists and nephrologists. A consensus statement from the Italian society of endocrinology (SIE), working group of the club nutrition-hormones and metabolism; the Italian society of nutraceuticals (SINut), club ketodiets and nutraceuticals "KetoNut-SINut"; and the Italian society of nephrology (SIN).非透析慢性肾脏病患者肥胖的营养评估和医学膳食治疗:内分泌学家、营养师和肾脏病学家实用指南。意大利内分泌学会(SIE)、俱乐部营养-激素和代谢工作组;意大利营养保健品学会(SINut)、酮饮食和营养保健品“KetoNut-SINut”俱乐部;以及意大利肾脏病学会(SIN)的共识声明。
J Endocrinol Invest. 2024 Dec;47(12):2889-2913. doi: 10.1007/s40618-024-02446-8. Epub 2024 Sep 18.
6
Effects of on ameliorating podocyte injury in ORG mice through TNF pathway and prediction of active compounds.通过肿瘤坏死因子(TNF)途径改善ORG小鼠足细胞损伤的作用及活性化合物预测
Front Pharmacol. 2024 Aug 21;15:1426917. doi: 10.3389/fphar.2024.1426917. eCollection 2024.
7
EGR3 reduces podocyte inflammatory damage in obesity related glomerulopathy by inhibiting the PRMT1pSTAT3 pathway.EGR3 通过抑制 PRMT1/pSTAT3 通路减少肥胖相关性肾小球病变中的足细胞炎症损伤。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Mar 28;49(3):349-358. doi: 10.11817/j.issn.1672-7347.2024.230394.
8
The New Challenge of Obesity - Obesity-Associated Nephropathy.肥胖的新挑战——肥胖相关性肾病
Diabetes Metab Syndr Obes. 2024 May 6;17:1957-1971. doi: 10.2147/DMSO.S433649. eCollection 2024.
9
Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD).肥胖与慢性肾脏病(CKD)的心脏代谢合并症及并发症
J Clin Transl Endocrinol. 2024 Apr 2;36:100341. doi: 10.1016/j.jcte.2024.100341. eCollection 2024 Jun.
10
Obesity Patterns, Metabolic Abnormality, and Diabetic Kidney Disease in Patients with Type 2 Diabetes.2型糖尿病患者的肥胖模式、代谢异常与糖尿病肾病
Diabetes Metab Syndr Obes. 2023 Dec 7;16:3999-4011. doi: 10.2147/DMSO.S436046. eCollection 2023.
脂联素通过抑制 ROS/NF-κB/NLRP3 炎症途径保护肥胖相关性肾小球病。
BMC Nephrol. 2021 Jun 10;22(1):218. doi: 10.1186/s12882-021-02391-1.
4
Extensive pleiotropism and allelic heterogeneity mediate metabolic effects of and .广泛的多效性和等位基因异质性介导 和 的代谢作用。
Science. 2021 Jun 4;372(6546):1085-1091. doi: 10.1126/science.abf1008.
5
Exercise training in the management of overweight and obesity in adults: Synthesis of the evidence and recommendations from the European Association for the Study of Obesity Physical Activity Working Group.运动训练在成年人超重和肥胖管理中的应用:欧洲肥胖研究协会体力活动工作组的证据综合与建议。
Obes Rev. 2021 Jul;22 Suppl 4(Suppl 4):e13273. doi: 10.1111/obr.13273. Epub 2021 Jun 2.
6
2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea.《2020年韩国肥胖研究学会韩国肥胖管理指南》
J Obes Metab Syndr. 2021 Jun 30;30(2):81-92. doi: 10.7570/jomes21022.
7
AGA Clinical Practice Guidelines on Intragastric Balloons in the Management of Obesity.美国胃肠病学会关于胃内球囊治疗肥胖症的临床实践指南。
Gastroenterology. 2021 Apr;160(5):1799-1808. doi: 10.1053/j.gastro.2021.03.003.
8
Curcumin analogue C66 attenuates obesity-induced renal injury by inhibiting chronic inflammation.姜黄素类似物 C66 通过抑制慢性炎症减轻肥胖诱导的肾脏损伤。
Biomed Pharmacother. 2021 May;137:111418. doi: 10.1016/j.biopha.2021.111418. Epub 2021 Feb 24.
9
Role of NLRP3 Inflammasome Activation in Obesity-Mediated Metabolic Disorders.NLRP3 炎性小体激活在肥胖介导的代谢紊乱中的作用。
Int J Environ Res Public Health. 2021 Jan 10;18(2):511. doi: 10.3390/ijerph18020511.
10
Obesity, kidney dysfunction, and inflammation: interactions in hypertension.肥胖、肾功能障碍和炎症:高血压中的相互作用。
Cardiovasc Res. 2021 Jul 7;117(8):1859-1876. doi: 10.1093/cvr/cvaa336.